Show simple item record

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

dc.contributor.authorKhunti, K.
dc.contributor.authorKarnieli, E.
dc.contributor.authorLiebl, A.
dc.contributor.authorLigthelm, R. J.
dc.contributor.authorNazeri, A.
dc.contributor.authorOrozco-Beltran, D.
dc.contributor.authorPan, C.
dc.contributor.authorRoss, S. A.
dc.contributor.authorSvendsen, A. L.
dc.contributor.authorVora, J.
dc.contributor.authorYale, J. -F.
dc.contributor.authorMeneghini, L. F.
dc.contributor.authorDamci, T.
dc.contributor.authorCaputo, S.
dc.contributor.authorDzida, G. J.
dc.contributor.authorJi, Q.
dc.contributor.authorKaiser, M.
dc.date.accessioned2021-03-03T15:06:24Z
dc.date.available2021-03-03T15:06:24Z
dc.date.issued2012
dc.identifier.citationKhunti K., Caputo S., Damci T., Dzida G. J. , Ji Q., Kaiser M., Karnieli E., Liebl A., Ligthelm R. J. , Nazeri A., et al., "The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries", DIABETES OBESITY & METABOLISM, cilt.14, sa.12, ss.1129-1136, 2012
dc.identifier.issn1462-8902
dc.identifier.otherav_3d34c193-84fd-4b3e-bbba-c3dda74bcb5d
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/45051
dc.identifier.urihttps://doi.org/10.1111/j.1463-1326.2012.01665.x
dc.description.abstractAims: Evaluate the safety and efficacy of once-daily insulin detemir initiated in routine clinical practice in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycaemic agents (OHAs).
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.titleThe safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
dc.typeMakale
dc.relation.journalDIABETES OBESITY & METABOLISM
dc.contributor.departmentUniversity Of Leicester , ,
dc.identifier.volume14
dc.identifier.issue12
dc.identifier.startpage1129
dc.identifier.endpage1136
dc.contributor.firstauthorID207319


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record